Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic algorithm-based studies.
暂无分享,去创建一个
J N Weinstein | K W Kohn | J. Weinstein | K. Kohn | Y. Pommier | Y Pommier | Y Fan | L M Shi | Y. Fan | L. M. Shi | L. M. Shi | Y. Fan
[1] Jae K. Lee,et al. Mining and Visualizing Large Anticancer Drug Discovery Databases , 2000, J. Chem. Inf. Comput. Sci..
[2] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[3] S. Hecht,et al. Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex. , 1999, Biochemistry.
[4] Y. Pommier,et al. [Topoisomerases I: new targets for the treatment of cancer and mechanisms of resistance]. , 1998, Bulletin du cancer.
[5] Y. Pommier,et al. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. , 1998, Biochimica et biophysica acta.
[6] S. Arbuck,et al. Clinical applications of the camptothecins. , 1998, Biochimica et biophysica acta.
[7] J N Weinstein,et al. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin. , 1998, Journal of medicinal chemistry.
[8] W G Hol,et al. A model for the mechanism of human topoisomerase I. , 1998, Science.
[9] J. Champoux,et al. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. , 1998, Science.
[10] J N Weinstein,et al. Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity. , 1998, Molecular pharmacology.
[11] M. Ratain,et al. Topoisomerase I Inhibitors. , 1997, The oncologist.
[12] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[13] J N Weinstein,et al. A protein expression database for the molecular pharmacology of cancer , 1997, Electrophoresis.
[14] Michael R. Boyd,et al. The NCI In Vitro Anticancer Drug Discovery Screen , 1997 .
[15] D. Rogers,et al. Some Theory and Examples of Genetic Function Approximation with Comparison to Evolutionary Techniques , 1996 .
[16] K. Kohn,et al. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. , 1995, Biochemistry.
[17] M. Wani,et al. Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture. , 1995, Cancer research.
[18] K. Lackey,et al. Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I. , 1995, Journal of medicinal chemistry.
[19] M. Boyd,et al. Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen , 1995 .
[20] D. Emerson,et al. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. , 1995, Cancer research.
[21] J N Weinstein,et al. Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents. , 1994, Journal of the National Cancer Institute.
[22] Y. Pommier,et al. Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions. , 1994, The Journal of biological chemistry.
[23] Anton J. Hopfinger,et al. Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..
[24] Y. Pommier,et al. Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials. , 1994, Journal of the National Cancer Institute.
[25] H. Burris,et al. Topoisomerase I inhibitors. An overview of the camptothecin analogs. , 1994, Hematology/oncology clinics of North America.
[26] D Faraggi,et al. Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of action. , 1994, Statistics in medicine.
[27] M. Grever,et al. Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's drug discovery program for cancer and AIDS , 1994, Stem cells.
[28] E K Rowinsky,et al. The current status of camptothecin analogues as antitumor agents. , 1993, Journal of the National Cancer Institute.
[29] W. Goddard,et al. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations , 1992 .
[30] J N Weinstein,et al. Neural computing in cancer drug development: predicting mechanism of action. , 1992, Science.
[31] J. Boehm,et al. Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity. , 1991, Journal of medicinal chemistry.
[32] J. Boehm,et al. Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity , 1991 .
[33] J. Freidman,et al. Multivariate adaptive regression splines , 1991 .
[34] L. Liu,et al. DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. , 1989, Cancer research.
[35] D A Scudiero,et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.
[36] K. Kohn,et al. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. , 1989, Cancer research.
[37] R. Hertzberg,et al. Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. , 1989, Journal of medicinal chemistry.
[38] R. D. Iii Cramer,et al. Comparative Molecular Field Analysis (CoMFA). Part 1. Effect of Shape on Binding of Steroids to Carrier Proteins. , 1988 .
[39] D A Scudiero,et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.
[40] Toshio Fujita,et al. The Correlation of Biological Activity of Plant Growth Regulators and Chloromycetin Derivatives with Hammett Constants and Partition Coefficients , 1963 .